Litcius/Paper detail

miR-635 Targets KIFC1 to Inhibit the Progression of Gastric Cancer

Fengyu Cao, Yong-Bin Zheng, Chao Yang, S Huang, Xiaobo He, Shilun Tong

2020Journal of Investigative Medicine18 citationsDOI

Abstract

(KIFC1) mRNA expression in GC tissues and paracancerous tissues and cells were detected by quantitative real-time PCR. KIFC1 protein expression in GC tissues and paracancerous normal tissues and cells was detected by immunohistochemistry and western blot. Cell proliferation was monitored by Cell Counting Kit-8 assay and 5-bromo-2'-deoxyuridine assay. Transwell assay was employed to detect the migration and invasion of GC cells. The dual-luciferase reporter gene assay was adopted to detect the targeting relationship between miR-635 and KIFC1. Compared with paracancerous tissues, miR-635 expression was remarkably decreased in GC tissues; conversely, KIFC1 expression was significantly increased. Compared with human normal gastric epithelial cell GSE-1, miR-635 expression was markedly decreased in GC cell lines. Meanwhile, KIFC1 expression was significantly increased, and the Kaplan-Meier Plotter database showed that its high expression was remarkably associated with poor prognosis. Additionally, miR-635 can negatively regulate KIFC1. miR-635 can target KIFC1 to inhibit proliferation, migration and invasion of GC cells. Collectively, miR-635 is lowly expressed in GC, and it inhibits proliferation, migration and invasion of GC cells via regulating KIFC1.

Topics & Concepts

CarcinogenesisWestern blotCell growthImmunohistochemistryBiologymicroRNAMolecular biologyReporter geneCell cultureCancer researchCancerCellCancer cellChemistryGene expressionGeneImmunologyGeneticsMicroRNA in disease regulationEpigenetics and DNA MethylationRNA modifications and cancer